Skip to content
Palladio Biosciences

Palladio Biosciences

Working to bring new hope to patients with orphan diseases of the kidney
  • Home
  • Polycystic Kidney Disease
  • Pipeline
  • Clinical Trials
  • Information Resources
  • About Us
  • News
  • Contact

Palladio Biosciences featured in BioCentury

March 9, 2018 Palladio Biosciences

Palladio Biosciences was featured in the Emerging Company Profile section of the March 8, 2018 edition of BioCentury.  The full…

Continue Reading →

Posted in: Publications

Palladio Biosciences Announces Presentations of New Data for Lixivaptan and Polycystic Kidney Disease during the American Society of Nephrology 2017 Annual Meeting

November 1, 2017 Palladio Biosciences

  –Data to be presented at ASN support the continued development of lixivaptan for polycystic kidney disease– NEWTOWN, PA: November…

Continue Reading →

Posted in: Press Release

Palladio Biosciences Receives Orphan Drug Designation from the U.S. FDA for Lixivaptan for the Treatment of Autosomal Dominant Polycystic Kidney Disease

October 4, 2017 Palladio Biosciences

– Orphan drug designation an important milestone for lixivaptan development program – Newtown, PA:  October 4, 2017.  Palladio Biosciences, Inc. (Palladio), a…

Continue Reading →

Posted in: Press Release

Palladio Biosciences Announces Appointment of Frank C. Condella, Jr. to Board of Directors

June 12, 2017 Palladio Biosciences

— Addition of Polycystic Kidney Expertise to Leadership Team — Newtown, PA: June 12, 2017. Palladio Biosciences, Inc. (Palladio) https://palladiobio.com/,…

Continue Reading →

Posted in: Press Release

Palladio Biosciences Formed to Develop Transformative Medicines for Orphan Diseases of the Kidney

May 23, 2017 Palladio Biosciences

— Repositioning Lixivaptan for Polycystic Kidney Disease — Newtown, PA:  May 23, 2017.  Palladio Biosciences, Inc. (Palladio) https://palladiobio.com/, a private…

Continue Reading →

Posted in: Press Release

Palladio Biosciences, Inc. Named “Best in Show” at Mid-Atlantic Bio Angels 1st Pitch Philadelphia Event

March 16, 2017 Palladio Biosciences

Palladio Biosciences, Inc. Named “Best in Show” at Mid-Atlantic Bio Angels 1st Pitch Philadelphia Event –  Press Release

Continue Reading →

Posted in: Publications

Post navigation

Page 2 of 2
← Previous 1 2

Archives

  • Press Release
  • Publications

Please note that lixivaptan is for investigational use only.

Palladio Biosciences
5 Walnut Grove Drive
Suite 120
Horsham, PA 19044
info@palladiobio.com

Copyright © Palladio Biosciences.